The enzymes
market size is expected to grow from USD 14.0 billion in 2024 to
USD 20.4 billion by 2029, reflecting a CAGR of 7.8% during this period. This
growth is driven by increasing global demand for enzymes across various
industries. In the food and beverage sector, enzymes improve product quality
and consistency, while in biofuels, they promote more efficient and sustainable
production methods. The pharmaceutical industry leverages enzymes for drug
formulation and disease treatment. Furthermore, the rising emphasis on eco-friendly
and cost-effective industrial processes is boosting enzyme applications in
detergents and textiles. Innovations in biotechnology are also leading to the
development of specialized enzymes for targeted uses, enhancing their demand.
Overall, the versatility and effectiveness of enzymes across multiple sectors
are fueling their increasing global demand, with market players actively
engaging in partnerships for industrial and specialty enzymes.Enzymes Market
Here are some trends
currently shaping the enzymes market:
- Increased Demand in Food and
Beverage: The rise in health-conscious consumers
has led to higher demand for enzymes in food processing, enhancing flavor,
texture, and nutritional content.
- Biotechnology Advancements: Innovations
in biotechnology are leading to more efficient enzyme production
processes, improving yield and reducing costs.
- Sustainable Practices: There’s
a growing emphasis on sustainability, driving the use of enzymes in
eco-friendly applications like biofuels, biodegradable plastics, and waste
management.
- Pharmaceutical Applications: The
use of enzymes in drug formulation and as therapeutic agents is expanding,
particularly in personalized medicine and biosimilars.
- Animal Feed Enzymes: The
demand for animal feed additives, particularly enzymes that improve
nutrient absorption and digestion, is on the rise due to the growing
livestock industry.
- Personal Care Products: Enzymes
are increasingly being incorporated into personal care and cosmetics for
their ability to enhance product efficacy and skin benefits.
Specialty Enzymes Expected
to Capture a Major Enzymes
Market Share During the Forecast Period.
Specialty enzymes are
crucial in the pharmaceutical and biotechnology sectors, particularly in
biopharmaceutical production involving monoclonal antibodies and gene
therapies, where precision and specificity are vital. For example, proteinase K
is commonly used in DNA and RNA extraction for genomic research, a field that
has seen heightened demand due to advancements in personalized medicine and
diagnostics. This segment of specialty
enzymes benefits from substantial R&D investments and
innovations. Companies such as Novozymes A/S (Denmark) and dsm-firmenich
(Switzerland) are focused on creating novel enzymes with enhanced stability and
activity tailored for specific industrial uses. A notable example is
dsm-firmenich’s launch of Maxilact Next in May 2023, which improves
lactose-free dairy production efficiency by 25% without compromising taste.
Additionally, supportive regulatory frameworks for biopharmaceuticals and the
rising incidence of chronic diseases that require advanced treatments further
drive the growth of specialty enzymes, reinforcing their market leadership.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46202020
Plant-Derived Enzymes
Capture a Major Share of the Enzymes Market.
Amylase, derived from barley
and wheat, plays a vital role in the brewing industry by breaking down starches
into fermentable sugars, enhancing both the efficiency and quality of beer
production. In the juice and wine sectors, pectinase sourced from fruits such
as apples and oranges is widely used to clarify beverages and boost juice
yield. Plant enzymes are also essential in the expanding market for plant-based
and vegan
products. For example, transglutaminase from plant sources improves
texture and binding in meat alternatives, addressing the growing consumer
demand for sustainable and ethical food choices. This trend is reinforced by
the increasing popularity of plant-based diets, which further drives the demand
for plant-derived enzymes. Companies like Novozymes have made significant
investments in developing enzyme solutions tailored to specific industry needs.
In March 2020, Novozymes A/S (Denmark) launched Saphera Fiber, a plant-derived
lactase enzyme aimed at increasing fiber content in dairy products while
lowering sugar levels, catering to health-conscious consumers.
Enzymes
Market Forecast: Asia Pacific to Experience the Highest Growth Rate
The Asia-Pacific region is
poised for significant growth in the enzyme market, influenced by unique
industry dynamics and regional trends. A major driver is the biopharmaceutical
sector, especially in countries like South Korea and Singapore, where the demand
for enzymes in drug manufacturing and bioprocessing is rising. These enzymes
are vital for processes such as protein expression, purification, and
modification, which are crucial for producing biologics like monoclonal
antibodies and vaccines. Additionally, the burgeoning healthcare and diagnostic
sectors in the region are rapidly increasing the need for specialty enzymes,
particularly for diagnostic assays, genetic testing, and therapeutic
applications, fueled by heightened investments in healthcare infrastructure and
research. Moreover, the thriving textile and detergent industries in countries
like Bangladesh and Vietnam present promising opportunities for enzyme
manufacturers. Enzymes are increasingly utilized in textile processing for
fabric softening, de-sizing, and denim finishing, as well as in detergent
formulations for enhanced stain removal and fabric care. As these sectors
evolve in response to changing consumer preferences and regulatory standards,
the demand for enzymes is expected to rise sharply, establishing the
Asia-Pacific region as a key driver of growth in the global enzyme market.
Key players in this market include BASF SE (Germany), International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Associated British Foods plc (England), Novozymes A/S (Denmark), Kerry Group plc. (Ireland), Dyadic International Inc. (US), Advanced Enzyme Technologies (India), Aumgene Biosciences (India), Amano Enzyme Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Adisseo (China).
